• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鞘氨醇激酶-1 在头颈部癌症中的作用。

The impact of sphingosine kinase-1 in head and neck cancer.

机构信息

Cancer Biology Program, University of Hawaii Cancer Center, 701 Ilalo Street, Honolulu, HI 96813, USA.

出版信息

Biomolecules. 2013 Aug 12;3(3):481-513. doi: 10.3390/biom3030481.

DOI:10.3390/biom3030481
PMID:24970177
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4030949/
Abstract

Head and neck squamous cell carcinoma (HNSCC) has a high reoccurrence rate and an extremely low survival rate. There is limited availability of effective therapies to reduce the rate of recurrence, resulting in high morbidity and mortality of advanced cases. Late presentation, delay in detection of lesions, and a high rate of metastasis make HNSCC a devastating disease. This review offers insight into the role of sphingosine kinase-1 (SphK1), a key enzyme in sphingolipid metabolism, in HNSCC. Sphingolipids not only play a structural role in cellular membranes, but also modulate cell signal transduction pathways to influence biological outcomes such as senescence, differentiation, apoptosis, migration, proliferation, and angiogenesis. SphK1 is a critical regulator of the delicate balance between proliferation and apoptosis. The highest expression of SphK1 is found in the advanced stage of disease, and there is a positive correlation between SphK1 expression and recurrent tumors. On the other hand, silencing SphK1 reduces HNSCC tumor growth and sensitizes tumors to radiation-induced death.  Thus, SphK1 plays an important and influential role in determining HNSCC proliferation and metastasis. We discuss roles of SphK1 and other sphingolipids in HNSCC development and therapeutic strategies against HNSCC.

摘要

头颈部鳞状细胞癌(HNSCC)具有高复发率和极低的生存率。目前有效的治疗方法有限,无法降低复发率,导致晚期病例的发病率和死亡率居高不下。晚期表现、病变检测延迟以及高转移率使 HNSCC 成为一种毁灭性疾病。本综述探讨了鞘氨醇激酶-1(SphK1)在 HNSCC 中的作用,SphK1 是鞘脂代谢中的关键酶。鞘脂不仅在细胞膜中起结构作用,还调节细胞信号转导途径,影响生物学结果,如衰老、分化、凋亡、迁移、增殖和血管生成。SphK1 是增殖和凋亡之间微妙平衡的关键调节剂。SphK1 的最高表达存在于疾病的晚期,并且 SphK1 表达与复发性肿瘤之间存在正相关。另一方面,沉默 SphK1 可减少 HNSCC 肿瘤生长并使肿瘤对辐射诱导的死亡敏感。因此,SphK1 在决定 HNSCC 增殖和转移方面起着重要而有影响力的作用。我们讨论了 SphK1 和其他鞘脂在 HNSCC 发展中的作用以及针对 HNSCC 的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d370/4030949/54c30ff86029/biomolecules-03-00481-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d370/4030949/5e36dcece53c/biomolecules-03-00481-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d370/4030949/54c30ff86029/biomolecules-03-00481-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d370/4030949/5e36dcece53c/biomolecules-03-00481-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d370/4030949/54c30ff86029/biomolecules-03-00481-g002.jpg

相似文献

1
The impact of sphingosine kinase-1 in head and neck cancer.鞘氨醇激酶-1 在头颈部癌症中的作用。
Biomolecules. 2013 Aug 12;3(3):481-513. doi: 10.3390/biom3030481.
2
Emerging role of sphingosine-1-phosphate signaling in head and neck squamous cell carcinoma.1-磷酸鞘氨醇信号通路在头颈部鳞状细胞癌中的新作用
Onco Targets Ther. 2016 May 31;9:3269-80. doi: 10.2147/OTT.S99989. eCollection 2016.
3
Increased radiation sensitivity of head and neck squamous cell carcinoma with sphingosine kinase 1 inhibition.抑制鞘氨醇激酶 1 可提高头颈部鳞状细胞癌的放射敏感性。
Head Neck. 2011 Feb;33(2):178-88. doi: 10.1002/hed.21418.
4
A role of sphingosine kinase 1 in head and neck carcinogenesis.丝氨酸激酶 1 在头颈部肿瘤发生中的作用。
Cancer Prev Res (Phila). 2011 Mar;4(3):454-62. doi: 10.1158/1940-6207.CAPR-10-0299. Epub 2011 Jan 5.
5
Sphingosine kinase 1 mediates head & neck squamous cell carcinoma invasion through sphingosine 1-phosphate receptor 1.鞘氨醇激酶1通过1-磷酸鞘氨醇受体1介导头颈部鳞状细胞癌的侵袭。
Cancer Cell Int. 2014 Aug 29;14(1):76. doi: 10.1186/s12935-014-0076-x. eCollection 2014.
6
The expression of sphingosine kinase-1 in head and neck carcinoma.鞘氨醇激酶-1 在头颈部癌中的表达。
Cells Tissues Organs. 2010;192(5):314-24. doi: 10.1159/000318173. Epub 2010 Jul 2.
7
Gold nanorod-sphingosine kinase siRNA nanocomplexes: a novel therapeutic tool for potent radiosensitization of head and neck cancer.金纳米棒-鞘氨醇激酶 siRNA 纳米复合物:一种新型治疗工具,可显著增强头颈部癌症的放射敏感性。
Integr Biol (Camb). 2012 Feb;4(2):132-41. doi: 10.1039/c1ib00060h. Epub 2011 Dec 7.
8
Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer.鞘脂代谢改变的基因芯片分析揭示了鞘氨醇激酶1在乳腺癌中的预后意义。
Breast Cancer Res Treat. 2008 Nov;112(1):41-52. doi: 10.1007/s10549-007-9836-9. Epub 2007 Dec 4.
9
MiR-124 acts as a tumor suppressor by inhibiting the expression of sphingosine kinase 1 and its downstream signaling in head and neck squamous cell carcinoma.在头颈部鳞状细胞癌中,微小RNA-124通过抑制鞘氨醇激酶1及其下游信号传导的表达发挥肿瘤抑制作用。
Oncotarget. 2017 Apr 11;8(15):25005-25020. doi: 10.18632/oncotarget.15334.
10
Inhibition of SphK1 reduces radiation-induced migration and enhances sensitivity to cetuximab treatment by affecting the EGFR / SphK1 crosstalk.抑制鞘氨醇激酶1(SphK1)可通过影响表皮生长因子受体(EGFR)/鞘氨醇激酶1(SphK1)的相互作用,减少辐射诱导的迁移并增强对西妥昔单抗治疗的敏感性。
Oncotarget. 2014 Oct 30;5(20):9877-88. doi: 10.18632/oncotarget.2436.

引用本文的文献

1
-Amplified and -A159V Hotspot-Mutated Head and Neck Cancer Sensitive to the Rac Inhibitor EHop-016 In Vivo: A Proof-of-Concept Study.对Rac抑制剂EHop-016体内敏感的扩增型及A159V热点突变型头颈癌:一项概念验证研究
Cancers (Basel). 2025 Jan 23;17(3):361. doi: 10.3390/cancers17030361.
2
Lipid metabolism reprogramming in head and neck cancer.头颈癌中的脂质代谢重编程
Front Oncol. 2023 Oct 20;13:1271505. doi: 10.3389/fonc.2023.1271505. eCollection 2023.
3
Targeting SphK1/2 by SKI-178 inhibits prostate cancer cell growth.靶向 SphK1/2 抑制前列腺癌细胞生长。

本文引用的文献

1
Roles, regulation and inhibitors of sphingosine kinase 2.鞘氨醇激酶 2 的作用、调控及抑制剂。
FEBS J. 2013 Nov;280(21):5317-36. doi: 10.1111/febs.12314. Epub 2013 Jun 7.
2
Oncogenic properties of sphingosine kinases in haematological malignancies.鞘氨醇激酶在血液系统恶性肿瘤中的致癌特性。
Br J Haematol. 2013 Jun;161(5):623-638. doi: 10.1111/bjh.12302. Epub 2013 Mar 25.
3
Combined Inhibition of Epidermal Growth Factor Receptor and Cyclooxygenase-2 as a Novel Approach to Enhance Radiotherapy.联合抑制表皮生长因子受体和环氧合酶-2作为增强放疗效果的新方法
Cell Death Dis. 2023 Aug 21;14(8):537. doi: 10.1038/s41419-023-06023-4.
4
Oral Sources of Salivary Metabolites.唾液代谢物的口腔来源。
Metabolites. 2023 Mar 29;13(4):498. doi: 10.3390/metabo13040498.
5
Downregulation of Lipid Phosphate Phosphatase 3 Correlates With Tumor-Infiltrating Immune Cells in Oral Cancer.脂质磷酸酶3的下调与口腔癌中的肿瘤浸润免疫细胞相关。
Cureus. 2022 Mar 27;14(3):e23553. doi: 10.7759/cureus.23553. eCollection 2022 Mar.
6
The anti-osteosarcoma cell activity by the sphingosine kinase 1 inhibitor SKI-V.鞘氨醇激酶1抑制剂SKI-V的抗骨肉瘤细胞活性
Cell Death Discov. 2022 Feb 3;8(1):48. doi: 10.1038/s41420-022-00838-4.
7
Bile reflux and hypopharyngeal cancer (Review).胆汁反流与咽癌(综述)。
Oncol Rep. 2021 Nov;46(5). doi: 10.3892/or.2021.8195. Epub 2021 Sep 24.
8
SphK1-targeted miR-6784 inhibits functions of skin squamous cell carcinoma cells.靶向 SphK1 的 miR-6784 抑制皮肤鳞状细胞癌细胞的功能。
Aging (Albany NY). 2021 Jan 19;13(3):3726-3741. doi: 10.18632/aging.202336.
9
Inhibitors of Ceramide- and Sphingosine-Metabolizing Enzymes as Sensitizers in Radiotherapy and Chemotherapy for Head and Neck Squamous Cell Carcinoma.神经酰胺和鞘氨醇代谢酶抑制剂作为头颈部鳞状细胞癌放疗和化疗的增敏剂
Cancers (Basel). 2020 Jul 26;12(8):2062. doi: 10.3390/cancers12082062.
10
Bioactive sphingolipid profile in a xenograft mouse model of head and neck squamous cell carcinoma.头颈部鳞状细胞癌异种移植小鼠模型中的生物活性神经鞘脂谱。
PLoS One. 2019 Apr 19;14(4):e0215770. doi: 10.1371/journal.pone.0215770. eCollection 2019.
J Cell Sci Ther. 2011 Oct 13;1(2). doi: 10.4172/2157-7013.s1-002.
4
Biological characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a selective sphingosine kinase-2 inhibitor and anticancer agent.3-(2-氨基乙基)-5-[3-(4-丁氧基苯基)-丙叉基]-噻唑烷-2,4-二酮(K145)作为一种选择性鞘氨醇激酶-2抑制剂和抗癌剂的生物学特性研究。
PLoS One. 2013;8(2):e56471. doi: 10.1371/journal.pone.0056471. Epub 2013 Feb 20.
5
siRNA-mediated down-regulation of ceramide synthase 1 leads to apoptotic resistance in human head and neck squamous carcinoma cells after photodynamic therapy.siRNA 介导的神经酰胺合酶 1 下调导致光动力疗法后人头颈部鳞状细胞癌细胞凋亡抵抗。
Anticancer Res. 2012 Jul;32(7):2479-2485.
6
Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate.抑制鞘氨醇激酶 2 会升高循环鞘氨醇 1-磷酸。
Biochem J. 2012 Oct 1;447(1):149-57. doi: 10.1042/BJ20120609.
7
Cancer treatment and survivorship statistics, 2012.癌症治疗与生存统计,2012 年。
CA Cancer J Clin. 2012 Jul-Aug;62(4):220-41. doi: 10.3322/caac.21149. Epub 2012 Jun 14.
8
Metformin prevents the development of oral squamous cell carcinomas from carcinogen-induced premalignant lesions.二甲双胍可预防致癌物诱导的口腔鳞癌前病变发展为口腔鳞状细胞癌。
Cancer Prev Res (Phila). 2012 Apr;5(4):562-73. doi: 10.1158/1940-6207.CAPR-11-0502. Epub 2012 Mar 31.
9
Ceramide synthase 6 knockdown suppresses apoptosis after photodynamic therapy in human head and neck squamous carcinoma cells.鞘氨醇合酶 6 敲低抑制人头颈鳞癌细胞光动力疗法后的细胞凋亡。
Anticancer Res. 2012 Mar;32(3):753-60.
10
Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1.新型、强效且特异性的鞘氨醇激酶-1 抑制剂调节细胞 S1P 水平。
Biochem J. 2012 May 15;444(1):79-88. doi: 10.1042/BJ20111929.